Immune cell–mediated venous thrombus resolution

Herein, we review the current processes that govern experimental deep vein thrombus (DVT) resolution.How the human DVT resolves at the molecular and cellular level is not well known, due to limited specimen availability.Experimentally, the thrombus resolution resembles wound healing, with early neutrophil mediated actions, followed by monocyte/macrophage mediated events, including neovascularization, fibrinolysis, and eventually collagen replacement.Potential therapeutic targets are described and coupling with site directed approaches to mitigate off target effects is the long-term goal.Similarly, timing of adjunctive agents to accelerate DVT resolution is an area that is only starting to be considered.There is much critical research that is needed in this area.